Published August 4, 2020
| Version v1
Publication
Integration of omics and bioinformatics to identify new therapeutic targets for Acinetobacter baumannii. Virulence role of CarO in Acinetobacter baumannii infections
Description
Acinetobacter baumannii remains a significant and difficult-to-treat pathogen that causes
a range of interactions with the human host from asymptomatic colonization and carriage
in the skin, intestinal tract, and respiratory tract to invasive infection, such as nosocomial
pneumonia or bacteraemia. Especially, this pathogen affects critically-ill and
immunocompromised patients admitted to Intensive Care Units (ICUs), causing them
severe infections, which are associated with long hospital stay and high mortality rates.
The success of this bacterium is due to a combination of several factors, highlighting its
extraordinary ability to develop antimicrobial resistance that results in the rapid
nosocomial spread of strains resistant to almost all known antimicrobials, including
including the last reservoirs of our antimicrobial arsenal such as the carbapenems,
worldwide. Thus, in the recent global priority list of antimicrobial-resistant bacteria of
the World Health Organization, carbapenem-resistant A. baumannii (CRAB) is
considered as a "critical priority" for the development of new antimicrobials, due to the
lack of therapeutic options. This situation has promoted the search of new therapeutic
strategies to deal with multidrug-resistant (MDR) A. baumannii strains displaying
additional carbapenem-resistance, and non-antimicrobial approaches aimed at bacterial
virulence factors may represent a promising alternative. Nevertheless, our knowledge on
A. baumannii pathogenesis and virulence traits is still relatively scarce. In this Doctoral
Thesis, and in order to stop the evolution of A. baumannii infections, we aimed to study
more deeply the pathogenesis of CRAB infections using omics and bioinformatics to
ultimately discover new therapeutic targets for anti-A. baumannii drugs.
Firstly, we studied MDR/CRAB isolates from tracheobronchial aspirate samples of ICU
adult patients who suffered A. baumannii bacteraemic ventilator-associated pneumonia
(VAP) or remained exclusively colonised by this pathogen. We analysed the in vitro and
in vivo virulence of these isolates, in order to know if the invasive isolates exhibited
higher virulence than the colonising ones, but no differences were found. Moreover, when
the whole-genome sequencing (WGS) data of these isolates were analysed following
different approaches, again we did not find any difference between both phenotypes
regarding their clonal relationship, antimicrobial resistance mechanisms, or known
virulence determinants. However, the invasive A. baumannii isolates exhibited higher levels of expression of the outer membrane protein (OMP) OmpA than the colonising
ones, suggesting that those phenotypes depend on the regulation of already-known or still
unknown virulence factors, instead of on the genomic content.
Secondly, six bacteraemic MDR/CRAB clinical isolates obtained from six clinically
homogeneous ICU adult patients with bacteraemia secondary to VAP, who were
subjected to optimal colistin treatment but with radically different clinical outcomes, were
comparatively analyzed by WGS complemented with proteomic and immunoblot
techniques. These analyses indicated that the carO gene, encoding for the second most
abundant β-barrel protein of the A. baumannii outer membrane (OM), CarO, was
interrupted by different disruptive events in the isolates from patients who recovered from
infection, while it was intact in the isolates from patients who did not survive. When the
virulence role of A. baumannii CarO was analyzed in model systems, an isogenic mutant
lacking carO (ATCC 17978 ΔcarO) showed lower ability in vitro to adhere and invade
cultured human lung epithelial cells, and exhibited a higher minimum lethal dose and a
lower dissemination potential into essential organs and fluids in a murine model of
peritoneal sepsis. All of the above deficiencies were reverted in the ATCC 17978 ΔcarO
mutant transformed with a carO expression plasmid restoring OM CarO levels. Thus, the
results presented here reveal a previously unnoticed virulence role for the A. baumannii
OMP CarO, which may be responsible of the poor clinical outcome and therefore a
potential target for the development of novel anti-A. baumannii drugs.
Additional details
Identifiers
- URL
- https://idus.us.es/handle//11441/100095
- URN
- urn:oai:idus.us.es:11441/100095